Position in WVE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,296,644
+$9,772,433 QoQ
Shares Held
1,772,228
+2351.0% QoQ
Ownership
0.899%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 237 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WVE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. WVE ranks #71 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in WVE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,296,644 | 1,772,228 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $524,211 | 72,305 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,524,244 | 266,132 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $1,764,581 | 271,474 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $860,956 | 106,554 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,860,049 | 716,253 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,431,380 | 418,461 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $541,749 | 108,567 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,759,017 | 285,092 | Shares | Defined | 2024-05-15 | |
| 2022-09-30 | $1,108,901 | 307,175 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,056,511 | 940,465 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,182,600 | 1,091,300 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,486,306 | 1,110,289 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,398,084 | 1,101,650 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,362,028 | 1,255,560 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,080,431 | 1,262,109 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,799,167 | 1,499,259 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,997,462 | 706,415 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,850,013 | 561,961 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $300,888 | 32,112 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||